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The relative contribution of causal 
factors in the transition from 
infection to clinical chlamydial 
disease
Bonnie L. Quigley  1, Scott Carver  2, Jon Hanger  3, Miranda E. Vidgen1 & Peter Timms1
Chlamydia is a major bacterial pathogen in humans and animals globally. Yet 80% of infections never 
progress to clinical disease. Decades of research have generated an interconnected network linking 
pathogen, host, and environmental factors to disease expression, but the relative importance of these 
and whether they account for disease progression remains unknown. To address this, we used structural 
equation modeling to evaluate putative factors likely to contribute to urogenital and ocular chlamydial 
disease in the koala (Phascolarctos cinereus). These factors include Chlamydia detection, load, and 
ompA genotype; urogenital and ocular microbiomes; host sex, age, weight, body condition; breading 
season, time of year; location; retrovirus co-infection; and major histocompatibility complex class II 
(MHCII) alleles. We show different microbiological processes underpin disease progression at urogenital 
and ocular sites. From each category of factors, urogenital disease was most strongly predicted by 
chlamydial PCR detection and load, koala body condition and environmental location. In contrast, 
ocular disease was most strongly predicted by phylum-level Chlamydiae microbiome proportions, 
sampling during breeding season and co-infection with koala retrovirus subtype B. Host MHCII 
alleles also contributed predictive power to both disease models. Our results also show considerable 
uncertainty remains, suggesting major causal mechanisms are yet to be discovered.
Chlamydia is a major bacterial pathogen world-wide, affecting humans, wildlife and livestock1–3. Although 
pathologic outcomes vary between hosts and the chlamydial species involved, common clinical manifestations 
include urogenital and ocular inflammation that can lead to severe pain and infertility, and blindness, respec-
tively. Other clinical conditions may occur, such as abortion, polyarthritis and pneumonia1,4. It is well-established 
that infection with Chlamydia does not always progress to clinical disease, with as many as 85–90% of men and 
women asymptomatically infected with Chlamydia trachomatis5–7. Similarly, a study of one population of koalas 
(Phascolarctos cinereus) in southeast Queensland, Australia found Chlamydia pecorum infection appears subclin-
ical 70% of the time8. This demonstrates that chlamydial infection alone is not sufficient to predict progression 
to a clinical disease state. In addition, there are many well-documented cases where severe chlamydial disease 
pathology is observed but no chlamydial organisms can be detected, in both humans9 and koalas8,10.
Clearly, chlamydial disease progression is the result of multiple factors acting through complex mechanisms. 
Over the years, different studies have identified possible factors that may contribute to disease progression. 
Associations between the amount of chlamydial organism detected (infection load) and clinical disease presenta-
tion/severity have been made in both human11 and koala12 contexts. As well, the chlamydial serotype or genotype 
present (based on the Major Outer Membrane Protein gene, ompA) has been linked to the progression of sympto-
matic disease in humans13 and koalas14, respectively. Other organisms in the host microbiome at the infection site, 
especially the presence of diverse microbial populations found in conditions like bacterial vaginosis, are impli-
cated in chlamydial infections in humans13,15. In the same context, co-infections with other sexually transmitted 
infections are also believed to have an impact13. At the level of host, physical characteristics like a host’s sex and 
age have been linked with some clinical disease presentations14,16, while in both humans and koalas, host immune 
1Faculty of Science, Health, Education and Engineering, University of the Sunshine Coast, 90 Sippy Downs Drive, 
Sippy Downs, Queensland, 4556, Australia. 2School of Natural Sciences, University of Tasmania, Private Bag 55, 
Hobart, Tasmania, 7001, Australia. 3Endeavour Veterinary Ecology, 1695 Pumicestone Road, Toorbul, Queensland, 
4510, Australia. Correspondence and requests for materials should be addressed to P.T. (email: p.timms@usc.edu.au)
Received: 28 March 2018
Accepted: 25 May 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific REPORTS |  (2018) 8:8893  | DOI:10.1038/s41598-018-27253-z
system genetics, such as Human Leukocyte Antigen (HLA) or Major Histocompatibility Complex (MHC) gene 
alleles have been linked to clinical disease outcomes17–21. Finally, external environmental factors, such as the time 
of year16 and environmental stress from urban and agriculture development22 have also been associated with 
koalas developing chlamydial disease in the wild.
Clearly, chlamydial disease has been extensively studied in both humans and koalas, with these hosts sharing 
a high degree of overlap in contributing factors to disease progression. These bodies of research have revealed 
that humans and koalas share comparable urogenital and ocular disease presentations and outcomes1,3. This cre-
ates opportunities for advances in koala chlamydial disease understanding to not only benefit this vulnerable 
Australian marsupial, but also contribute valuable knowledge to chlamydial research in humans and other hosts.
A range of modelling studies have investigated chlamydial infection leading to disease (particularly focused 
on pelvic inflammatory disease23), but none has investigated the range of contributing factors in a unified analysis. 
To close this gap, we developed structural equation models (SEMs) for urogenital and ocular chlamydial clinical 
disease, using the koala as a model system. SEMs are used to analyse both direct and indirect relationships in a 
system where a priori knowledge of relationships between factors is available24. SEMs have been popular in the 
social and behavioral sciences for many years, and their ability to handle multi-equation models, multiple meas-
ures of concepts, and measurement error is making them applicable to a wider range of disciplines25. As such, 
SEMs can be a valuable tool to understanding how multiple factors come together in a disease setting. Using this 
approach, we determined that different contributing factors lead to clinical urogenital and ocular chlamydial 
disease. We also show that considerable unexplained variation remains and, thus, more factors may need to be 
considered in order to understand the progression of chlamydial infection to clinical disease.
Results
Establishing the urogenital and ocular disease models. Evaluating factors for the structural equation 
models. To model what factors predict clinical urogenital and ocular chlamydial disease, data from 204 wild 
koalas were collected on a range of chlamydial infection, environmental, koala physical and microbiome, and 
co-infection parameters (Table 1, extended descriptions in Supplementary Table 1 and Supplementary Methods). 
Ocular microbiome data was only obtainable from 111 koalas, hence the ocular clinical disease model was limited 
to the 111 koalas for which all data were available.
Preliminary structural equation models were designed as starting models based on a priori knowledge of 
urogenital and ocular chlamydial disease in koalas. Then, through a systematic backward elimination process 
with model selection, using Akaike Information Criterion corrected for small sample size (AICc), the most par-
simonious models describing chlamydial disease status was determined. Each model alternative had to satisfy 
basic model fit parameters to be considered valid, then AICc was used to assess the relative importance of models, 
and R2 goodness of fit. If the model version being tested generated a lower AICc than the starting model, the test 
model became the new starting model for further testing (Supplementary Table 2). A final model for urogenital 
and ocular disease was reached when backward elimination no longer improved AICc. SEM analysis revealed 
that, based on the factors that best modelled the data, 43.0% of clinical urogenital disease (Fig. 1A) and 45.5% of 
clinical ocular disease (Fig. 1C) could be accounted for.
Factors included and excluded from the final models. From the factors related to C. pecorum, both models 
retained a measure of infection status (detection of C. pecorum at the site by qPCR). A 3-level C. pecorum detec-
tion factor (not detected, detected at low levels (below 100 copies/µl of sample), and detected at high levels (above 
100 copies/µl of sample)) was more optimal for the prediction of urogenital disease while a 2-level C. pecorum 
detection factor (not detected verses detected) was preferred in the ocular model (Fig. 2A). Both urogenital and 
ocular models retained a factor for C. pecorum load (in log copies/µl of sample) (Fig. 2B) while neither model 
found C. pecorum ompA genotype improved the model (therefore, C. pecorum genotype was removed from both 
models).
Since microbiome composition could be represented at a range of levels, factors were created that summarized 
these data at the phylum-level (for the five major phyla detected, Fig. 2C), the genus-level (for genera that had 
statistically different means between healthy and clinical disease states, Supplementary Fig. 1) and OTU-level 
(manually chosen from Bray-Curtis dissimilarity clustering analysis, Supplementary Figs 2 and 3). Surprisingly, 
the phylum-level data generated the best AICc statistics in model evaluation as the preferred format of the factor. 
An interesting observation about the phylum-level Chlamydiae group was that it comprised of at least 99.9% 
C. pecorum in all samples. All non-C. pecorum Chlamydiae were detected in both urogenital and ocular microbi-
omes made up no more than 0.1% of the total phylum-level Chlamydiae26. Non-taxonomic grouping strategies, 
such as clustering analysis, generated poorer AICc statistics than phylum-based grouping (Supplementary Figs 2 
and 3 and Supplementary Table 2). Finally, a factor was created to indicate whether the microbiome was domi-
nated (comprised of >75%) by a single OTU. This “monolithic microbiome” factor improved the model for ocular 
clinical disease only and was retained there.
All the koala physical factors considered (sex, age, weight and overall body condition (Fig. 3A)) were math-
ematically advantageous to both models and were retained in the final models. From the environmental factors 
evaluated, sampling for disease in the context of a short koala breeding season (September to December) (Fig. 3B) 
improved both disease models compared to a longer breeding season (July to January) and seasons of the year 
(spring/summer/autumn/winter). Location within the study site, which served as a proxy to capture environmen-
tal differences such as food availability, disturbance by urban development, predators in the area, and existing 
pockets of chlamydial disease (Fig. 3C), was a factor that improved both urogenital and ocular models.
Finally, evaluation of co-infection was done by considering both koala retrovirus (KoRV) and chlamydial 
disease at the body site not being actively modeled. KoRV was captured with a factor for KoRV-B infection (all 
koalas were KoRV-A positive) (Fig. 4). KoRV-B infection was included as a co-variance with clinical chlamydial 
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disease, since it is currently unknown how KoRV infection affects chlamydial disease and vice versa. A factor 
representing the different envelope types of KoRV-B in the population was tested in each model and found not 
to enhance either model. Chlamydial disease at the alternative body site was evaluated as both an infection factor 
(C. pecorum not detected/detected by qPCR) and clinical disease assessed at the site. For urogenital disease, the 
ocular infection and disease factors improved the model and were retained. For ocular disease, the urogenital 
infection and disease factors did not improve the model and were removed.
Urogenital and ocular disease progression is influenced by different factors. Microbiological 
influences on urogenital and ocular disease. For urogenital disease prediction, the detection (standardised coef-
ficient (SC) = 1.269) and load (SC = −1.030) of C. pecorum at the infection site were by far the most predictive 
disease factors (Fig. 1A,B). The presence or absence of detectable C. pecorum corresponded to the clinical disease 
status in 80% of cases (Fig. 2A). C. pecorum load contribute to disease prediction with non-zero detectable loads 
found in 57% of disease cases. The negative effect of load resulted from a slightly lower median level of C. pecorum 
detected in clinically diseased koalas (44 copies/µl) compared to infected, asymptomatic koalas (65 copies/µl) 
(Fig. 2B). However, this load difference was non-significant (t(49) = 1.255, p = 0.215) and only 11% of healthy 
koalas carried C. pecorum asymptomatically while 57% of clinically diseased koalas were infected. Additionally, 
microbiome phylum-level factors contributed approximately five times less than direct C. pecorum factors, with 
increasing levels of Firmicutes (SC = 0.179) and Chlamydiae (SC = 0.204) detected in the urogenital microbiome 
adding to disease prediction (Fig. 2C). Together microbiological methods reveal that 82% of clinical urogeni-
tal disease cases and only 31% of asymptomatic infected koalas had detectable C. pecorum (or a close relative) 
(Table 2).
Conversely, detection (SC = −0.142) and load (SC = 0.273) of C. pecorum was much less predictive for ocular 
disease prediction (Fig. 1C,D). Detection of C. pecorum corresponded with active clinical disease in only 45% of 
cases (Fig. 2A) and there was no significant difference between C. pecorum non-zero loads in infected, asympto-
matic koalas (median 4 copies/µl, 3% of ocular healthy koalas) and ocular diseased koalas (median 76 copies/µl, 
55% of diseased koalas); t(9) = −2.059, p = 0.070. In ocular disease, the most predictive factor was the proportion 
of the ocular microbiome that was comprised of Chlamydiae (SC = 0.524). Koalas with clinical ocular disease had 
Category Factor Description of factor Alternative versions of factor (if considered)
Clinical disease status Urogenital disease Clinical reproductive and/or urinary/renal disease as assessed by physical exam and ultrasound
Ocular disease Clinical ocular disease as assessed by physical exam and ultrasound
Any chlamydial disease Clinical reproductive, urinary/renal and/or ocular disease as assessed by physical exam and ultrasound
Host physical Age Koala age assessed by tooth wear or known interaction history
Sex Koala sex as assessed by physical exam
Weight Koala weight (in kg)
Body condition Koala overall body condition, assessed by physical exam on 6 point scale; 3 (poor) - 9 (excellent)
Environmental Time of year Time of year sample collected
4 seasons (spring/summer/autumn/winter); breeding 
season (out [Jan-Aug]/in [Sept-Dec]); breeding season 
longer (out [Feb-Jun]/in [Jul-Jan])
Location in study site Subsite location (1–5) within study region
Chlamydia infection Infection status Detection of Chlamydia pecorum at site via qPCR
2-level detection (no/yes); 3-level detection (no/low 
positive (<100 copies/µl)/high positive (>100 copies/
µl))
Infection load qPCR copies/µl sample detected copies/sample; log transformed copies/sample
Chlamydia genotype ompA genotype (E’, F, G, mixed)
Co-infections Koala retrovirus detection
KoRV-B provirus detected in host genome via 
conventional PCR
Koala retrovirus 
subtype Sequence type based on envelope protein fragment
Microbiome Overall composition Percentage of each sample microbiome composed of group indicated Phylum-level; genus-level; OTU-level
Single OTU dominated Microbiome comprised of >75% single OTU (monolithic)
Cluster analysis Grouping of OTU-level microbiome composition by 75% Bray-Curtis dissimilarity values
Host MHC class II 
genetics Gene class profiles DAb allele profile; DBb allele profile
Individual alleles
DAb*10; DAb*15; DAb*19; DAb*21; DAb*30; DAb*31; 
DAb*32; DAb*33; DAb*34; DAb*35; DAb*36; DBb*01; 
DBb*02; DBb*03;  
DBb*05
Table 1. Summary of chlamydial disease factors considered for disease modelling.
www.nature.com/scientificreports/
4Scientific REPORTS |  (2018) 8:8893  | DOI:10.1038/s41598-018-27253-z
detectable Chlamydiae in their eye in 82% of cases (Table 2). Within these diseased Chlamydiae-positive koalas, 
the bacteria ranged from 1–92% of the total ocular microbiome. This contrasted with ocular healthy koalas, which 
had detectable Chlamydiae in their eye in only 43% of cases, with ranges of <0.1–12% of the total ocular microbi-
ome. Also unique to the ocular disease analysis, it was determined that having a diverse microbiome contributed 
predictive power to clinical ocular disease (SC = −0.146).
Physical influences on urogenital and ocular disease. In both urogenital and ocular disease models, respectively, 
both age (SC = 0.560 and 0.591) and sex (SC = 0.514 and 0.514) strongly predicted a koala’s weight, but weight 
was not a major predictor of either clinical disease status (SC = 0.081 and −0.003) (Fig. 1A,C). A koala’s body 
condition was much more predictive for urogenital disease (SC = −0.165) than ocular disease (SC = −0.055), 
suggesting that koalas with poor body condition (for whatever reason – such as fighting, injury, other illnesses, or 
current chlamydial disease) were more likely to be diagnosed with urogenital disease compared to ocular disease. 
This was reflected in the population where koalas with clinical urogenital disease had a median body score of 6 
compared to urogenital healthy koalas’ median body score of 7 (Mann-Whitney U = 2511, p < 0.001). Ocular 
diseased and healthy koalas both had median body scores of 7 (Mann-Whitney U = 833, p = 0.200) (Fig. 3A).
Environmental influences on urogenital and ocular disease. For urogenital disease prediction, the time of year 
the koala was sampled (in or out of their breeding season) had virtually no predictive power on clinical disease 
presentation (SC = −0.071) (Fig. 1A). Conversely, for ocular disease, there was some positive predictive power 
of sampling during the breeding season (SC = 0.113) (Fig. 1C). Based on the time of year when koalas were diag-
nosed with clinical disease, 34% of urogenital disease and 36% of ocular disease was seen during breeding season 
(non-significant proportions) (Fig. 3B). The location where the koala was found in the study site had some pre-
dictive power for urogenital disease (SC = 0.186), but not for ocular disease (SC = −0.032). This is in agreement 
with the known distribution of urogenital and ocular disease in this area, with urogenital disease distribution 
significantly localized to some areas (Mann-Whitney U = 2663, p < 0.001) while ocular disease had a uniform 
distribution in the study site (non-significant distribution) (Fig. 3C).
Co-infection. Koalas with clinical urogenital disease were just as likely to be infected with KoRV-B (32%) as 
koalas without urogenital disease (22%) (χ2(1) = 2.015, p = 0.156), resulting in this factor having no predictive 
Figure 1. Structural equation models diagramming the factors influencing chlamydial disease at (A) urogenital 
(n = 204) or (C) ocular (n = 111) sites. Factors considered in the model are diagrammed in boxes with 
descriptions of that factor in parenthesis. The value on the arrow represents the amount of variance explained 
by the factor at the start of the arrow on the factor at the end of the arrow. The farther the value is from zero, the 
larger the influence (thicker the arrow in the diagram), with values comparable across the model. Solid arrows 
indicate positive effect; dashed arrows indicate negative effect; double-headed red arrows indicate co-variance. 
Summary of the standardized coefficients from (B) urogenital and (D) ocular models.
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power (SC = 0.000) (Figs 1A and 4A). By comparison, koalas with clinical ocular disease were significantly more 
likely to be infected with KoRV-B (64%) than koalas without ocular disease (23%) (Fisher’s Exact Test, p = 0.006), 
lending much more predictive power to this factor (SC = 0.250) (Figs 1B and 4B).
Figure 2. Microbiological factors that influence Chlamydia disease modelling. (A) C. pecorum detection via 
qPCR, at either 3 levels of detection for the urogenital site (not detectable, detectable not quantifiable (<100 
copies/µl sample) and detectable and quantifiable (>100 copies/µl sample) or 2 levels of detection for the ocular 
site (not detectable and detectable). (B) Non-zero copy number of C. pecorum 16 S rRNA genes detected in 
urogenital and ocular samples via qPCR by clinical disease states. Median values are indicated by the red dashed 
line. (C) Microbiome compositions at the phylum level of urogenital and ocular sites by clinical disease state. 
Significances are indicated by *(p < 0.05), **(p < 0.01) or not significantly different (ns).
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While the inclusion of ocular infection and disease factors added to the overall model fit for urogenital dis-
ease, the analysis revealed that knowing the ocular chlamydial infection and disease status contributed very little 
to urogenital disease prediction (SC = −0.076 and −0.041, respectively).
Figure 3. Physical and environmental factors that influence Chlamydia disease modelling. (A) Body conditions 
by urogenital and ocular disease. Median values are indicated by the red dashed line. (B) Breakdown of clinical 
urogenital and ocular disease observed by breeding season. (C) Distribution of urogenital (UGT) and ocular 
(OC) disease within the regions of the study site. Background colours on the map represent water (blue), green 
space (green) and urban development (tan). The white line represents a train line through the area. Pie charts 
represent chlamydial disease within a region with black slices indicating disease and white slices indicating 
health. Significances are indicated by ***(p < 0.001), and not significantly different (*ns).
www.nature.com/scientificreports/
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Major factors still missing from clinical disease explanations. Major Histocompatibility Complex 
(MHC) host genetics. Given that the current models only account for 43% of urogenital disease and 46% of ocu-
lar disease, it was clear that addition factors are important for clinical disease progression. As a preliminary next 
step, we identified a set of MHC class II gene alleles for a subset of the koalas in this study (DAb and DBb gene 
alleles, n = 57). From our koalas, 11 alleles of DAb were detected, of which five have been previously reported 
(DAb*10, DAb*15, DAb*19, DAb*21, and DAb*30) and six are novel to this study (DAb*31 to DAb*36). All 
four of the DBb alleles detected in this population have been previously reported (DBb*01, DBb*02, DBb*03, 
and DBb*05) (Supplementary Fig. 4). Evaluated individually, DBb*03 was the only allele to be associated with a 
clinical outcome; overall clinical chlamydial disease (at any body site) was associated with the absence of DBb*03 
(χ2(1) = 4.466, p = 0.035).
We took our best fit ocular and urogenital SEMs and explored if adding MHC factors added greater explana-
tory power to chlamydial disease status. This is necessarily a preliminary analysis, as reducing the number of koa-
las for model generation, as well as adding additional free parameters, challenges standard rules for the number 
of samples/factor recommended in SEMs27–29. MHC alleles were tested by adding each allele factor to the existing 
model either individually, or as a composite DAb or DBb profile factor. Factors that improved model goodness of 
fit were combined into a final preliminary MHC-inclusive model for each body site. In both urogenital and ocular 
models, our tentative findings indicate that the addition of alleles DAb*21, and DAb*32 to DAb*36 added to the 
variation in chlamydial disease explained, with an additional 7% of urogenital disease and 2% of ocular disease 
accounted for with this additional host immune genetic information (Supplementary Figs 5 and 6).
Discussion
Over the many years of Chlamydia research, with multiple hosts and species of Chlamydia pathogens, a discon-
nect between infection and disease has existed: infection with a chlamydial pathogen does not always lead to 
clinical disease and, during clinical disease, the instigating chlamydial pathogen cannot always be detected. This 
suggests that more than just the chlamydial pathogen is necessary to progress from infection to disease and that 
clinical signs and pathological changes can persist with undetectable levels of the chlamydial organism. Over the 
years, several microbiological, host and environmental factors have been implicated in contributing to clinical 
disease, but no attempt had yet been made to combine these factors into a predictive model of clinical chlamydial 
disease to aid in understanding their complex relationships. To redress this gap, this study unified a range of 
Figure 4. Co-infection status with koala retrovirus subtype B (KoRV-B) in (A) urogenital and (B) ocular 
clinical disease. Significances are indicated by ** (p < 0.01) and not significantly different *(ns).
Disease site Disease status
Number of koalas
C. pecorum 
detectable 
by qPCR
C. pecorum 
detected in 
microbiome
Any non-C. pecorum 
Chlamydiae detected 
in microbiome
Any Chlamydiae 
(including C. pecorum) 
detected in microbiome
No C. pecorum detected by qPCR 
AND No other Chlamydiae 
detected in microbiome
Urogenital Disease (n = 60) 34 (57%) 48 (80%) 2 (3%) 49 (82%) 11 (18%)
Healthy (n = 144) 17 (12%) 40 (28%) 7 (5%) 45 (31%) 99 (69%)
Ocular Disease (n = 11) 5 (45%) 9 (82%) 2 (18%) 9 (82%) 2 (18%)
Healthy (n = 193) 5 (3%) na na na na
Healthy with 
microbiome data 
(n = 101)
5 (5%) 36 (36%) 11 (11%) 43 (43%) 58 (57%)
Table 2. Summary of Chlamydial microbiological contributors to disease prediction.
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factors that were known or hypothesized to contribute to clinical chlamydial disease in the koala, and used SEM 
to model their effect on chlamydial disease prediction. Although koalas were used as a model in this analysis, 
many of the same factors have been implicated in chlamydial disease in humans and other animals. Therefore, 
advances in our understanding of chlamydial disease factors in general has implications that reach across host 
species and health/medical disciplines. The parallels between koala C. pecorum and human C. trachomatis dis-
ease, in particular, make findings in koalas very relevant to human Chlamydia research. The result from our 
analysis has been a clear separation of chlamydial urogenital and ocular diseases as separate processes, governed 
by distinct microbiological, host and environmental factors. In addition, despite the breadth of factors already 
under active research consideration, more than half of the clinical disease observed at each body site is influenced 
by factors that are not commonly considered.
Not surprisingly, the most heavily weighted factors that influenced disease progression in these models were 
the C. pecorum microbiological factors. What was interesting was the finding that C. pecorum results (detection 
and load) were better predictors of urogenital disease while phylum-level Chlamydiae microbiome proportions 
were better at predicting ocular disease. The poor association of chlamydial load with ocular disease noted here is 
consistent with immunohistochemistry studies, where inclusions can be rare despite florid conjunctival inflam-
mation and tissue proliferation9,30. Within the context of a multi-factor regression model, the ability of the qPCR 
to perform better at detecting C. pecorum in urogenital disease situations added to its significance while the larger 
difference in C. pecorum microbiome proportions between ocular disease states gave that factor more weight in 
the ocular disease model. These subtle differences, highlighted by the SEM approach, reflect genuine biological 
differences between C. pecorum infections at the two body sites.
The other factors considered in these disease models contributed relatively smaller proportions to the overall 
predictive power of clinical chlamydial disease, however, they continued to highlight the differences between 
urogenital and ocular disease. A koala’s body condition and environmental location had the greatest impacts on 
whether an animal was predicted to have urogenital disease. The way the body condition score was incorporated 
in the models meant that if a koala was captured from the wild and scored with a lower overall body score, it was 
more likely to have urogenital disease than ocular disease. This could represent either a situation where a koala 
was impacted by an injury or unrelated illness that predisposed them to urogenital chlamydial disease develop-
ment or that a koala had urogenital disease prior to its capture and that disease state had more of an impact on 
its body condition than ocular disease would. It is, of course, accepted that major injury or prolonged chlamydial 
disease at either site would negatively impact body condition, but in the context of the factors considered in each 
model, body condition decline was more predictive of urogenital disease than ocular disease. Additionally, the 
environmental location of the koala had an impact on whether it was predicted to have active urogenital disease. 
Different study locations had different levels of stressors, which included more interaction with urban housing, 
different food availability, and different predators in the area. Interestingly, the region with the highest urogenital 
chlamydial disease (region 5, 68%) was a greenspace away from the urban housing developments. This implies 
that close contact with human habitation is not a sole indicator of an environment where koalas are more likely 
to develop chlamydial disease. How interactions with humans, predators, space and food resources influence 
chlamydial disease progression is currently not understood, but these results show that the location impacts uro-
genital disease differently than ocular disease.
From the ocular disease perspective, sampling during breeding season and co-infection with KoRV-B were the 
non-microbiological factors that contributed most to clinical disease prediction. The link to breeding season sug-
gests that contact between koalas during mating or male-to-male fighting over territory or mates may contribute 
to this factor’s predictive power for ocular disease during this time. It is also possible that stressors and/or hor-
mones during mating season influence ocular disease signs differently than urogenital signs. Another contributor 
was co-infection with KoRV-B. Infection with KoRV-B has been linked to clinical chlamydial disease8,31. Within 
these models, co-infection with KoRV-B was significantly linked to more clinical ocular disease only. In previous 
KoRV-B/Chlamydia studies, as well as in our current models, the severity of urogenital and ocular disease was not 
factored into the analysis, nor was the type of urogenital disease (urinary tract disease verses reproductive tract 
disease). Defining both urogenital and ocular disease more precisely in future analyses may help focus the results 
of KoRV-B influence onto the key chlamydial disease conditions affected. At present, the mechanism of interac-
tion between KoRV and chlamydial disease is currently unknown and is an area of active research.
Beyond the factors considered in these chlamydial disease models, this analysis clearly demonstrated con-
siderable unexplained variation in determining the progression to both urogenital and ocular disease. In their 
current form, the models do not contain any Chlamydia cellular properties, host genetic components or immune 
response measures. It was surprising that chlamydial genotype (based on the ompA surface protein) did not 
improve the models, as this factor has been linked to clinical disease in the past14. However, other chlamydial 
properties, such as the presence of plasmids32, type III secretion system properties33, activities of self-peptide 
presentation mechanisms34, or the ability to down regulate MHC class I molecules35, are all alternative character-
istics that could add predictive power to a clinical disease model. From the host genetic component, preliminary 
analysis suggested that host MHC class II gene alleles do contribute predictive power to clinical chlamydial dis-
ease. Additional host genes that could be considered further include interleukin (IL)−12B, IL-10, tumor necro-
sis factor (TNF)-α, and interferon (IFN)-γ genes17,36,37. Finally, measuring the immune response directly will 
undoubtedly contribute to the modeling of disease progression. IFN-γ levels (often considered the primary driver 
of a protective chlamydial host response and optimal antibody-mediated immunity)37,38, T-cell responses39 and 
B-cell responses40 would all be valuable factors to investigate in future modeling. Despite the absence of these 
factors in the current analysis, an advantage of the approach taken in this study is that the models generated give 
an indication of the relative importance of both the factors considered and of the proportion of “missing” data 
yet to be investigated. Importantly, this research suggests major causal mechanisms of chlamydial disease are yet 
to be discovered.
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There are many parallels in symptomatic chlamydial disease between hosts. Many of the factors that have been 
shown or hypothesized as important in koala Chlamydia pathogenesis have counterparts in human Chlamydia 
research. The chlamydial SEM models generated in this study demonstrate that modeling can successfully find 
associations and relationships that might otherwise be missed in individual, factor-focused studies. Additionally, 
by looking at several factors in a combined approach, the relative weight and importance of each factor can be 
assessed in the context of all the others. This makes SEM a powerful tool to unravel the complexity of chlamydial 
pathogenesis in any species.
Materials and Methods
Animals. Koalas included in the study (n = 204) were part of a multi-year population-wide management 
program by the Queensland Government Department of Transport and Main Roads for the Moreton Bay Rail 
(MBR) project, in the Moreton Bay Region, Queensland, Australia (project centre-point: 27.25°S,153.02°E). All 
procedures were approved by the University of the Sunshine Coast (USC) Animal Ethics Committee (Animal 
ethics number AN/A/13/80) and by the Queensland Government (Scientific Purposes Permit, WISP11532912). 
All experiments were performed in accordance with relevant guidelines and regulations.Detailed description of 
koala sampling has been previously reported8 and is found in Supplementary Methods.
Model parameter data. Data used for clinical disease parameters, physical koala characteristics, location 
parameters, Chlamydia infection parameters and KoRV infection parameters have all been previously reported8. 
The urogenital and ocular microbiome data referred to in this study were generated previously26. Detailed 
descriptions of parameter data is given in Supplementary Methods.
Host genetics. For a subset of koalas (n = 57), MHC class II DAb and DBb gene alleles were determined. 
Koalas were selected from the study population by determining which animals had the greatest depth in their 
ocular microbiome dataset (as the ocular microbiome data parameter was the experimental parameter with the 
least overall sequencing depth available). The 57 koalas with the most ocular microbiome reads maintained a 
comparable representation of chlamydia disease states and KoRV-B results to the overall population and were 
deemed suitable as a subset for MHC examination. Using the DNA extracted from whole blood, PCR for the DAb 
(271 bp product) and DBb (282 bp product) gene was carried out as previously described21,41. PCR products were 
cloned into pGEM-T-Easy TA cloning vector system (Promega) as per manufacturer’s instructions. Six clones per 
gene target per sample were isolated and sequenced (Macrogen, Inc). Sequences were examined to determine the 
number and allele type present in each animal. Novel allele types (DAb*31 to DAB*36) have been deposited in 
Genbank under the accession numbers MG957484-MG957489.
Structural equation modeling. Preliminary structural equation models were designed as starting models 
based on a priori knowledge of urogenital and ocular chlamydial disease in koalas (Supplementary Fig. 7). Then, 
using the lavaan package of R42, systematic model evaluation was undertaken to test factors using a backward 
elimination process and model selection to find the most parsimonious model (Supplementary Table 2). Each 
model tested had to satisfy three model fit parameters: Bollen-Stine P-value (>0.05), the Confirmatory Fit Index 
(CFI) (>0.9) and the Root Mean Square Error of Approximation (RMSEA) (<0.1). Once these parameters were 
satisfied, the Akaike Information Criterion corrected for small-sample-size (AICc) was used to assess the relative 
importance of a model and R2 calculated to estimate the goodness of fit for the model, using the AICcmodavg 
package in R43. If the model version being tested generated a lower AICc, the test model became the new starting 
model for further backward elimination testing (Supplementary Table 2). A final model for urogenital and ocular 
disease was determined when no further variable elimination improved model fit by AICc.
Data availability. Accession numbers for MHC class II allele sequences generated in this study can be found 
at GenBank MG957484-MG957489.
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